Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis
Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis
复制标题
DOI：
10.1536/ihj.17-315
复制
发表时间：
2018-05-01
影响因子：
1.5
通讯作者：
Ishizaka, Nobukazu
中科院分区：
文献类型：
--
作者：
Terasaki, Fumio;Fujita, Shu-ichi;Ishizaka, Nobukazu
Fluorine-18 fluorodeoxygluose (F-18-FDG) positron emission tomography (PET) is a useful tool for evaluating disease activity in sarcoidosis including cardiac involvement. A 67-year-old patient who developed atrioventricular block requiring permanent pacemaker implantation was diagnosed with cardiac sarcoidosis. The patient did not undergo steroid or immunosuppressive therapy but underwent serial F-18-FDG PET examination, which showed spontaneous reduction in the myocardial FDG uptake, indicating the remission of immune-inflammatory activity. Although the global systolic function remained preserved, thinning of the septal wall emerged during the clinical course of follow-up, which is characteristic for cardiac sarcoidosis.
